Submit Deal

KYOWA KIRIN (CHINA BUSINESS)

Summary

Kyowa Kirin is a global specialty pharmaceutical company that applies state-of-the-art biotechnologies to discover and deliver novel medicines.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 78 M

Avg. Deal Size£ 78 M

Market Context

Sort

Target: KYOWA KIRIN (CHINA BUSINESS)

Bidder: HONG KONG WINHEALTH PHARMA GROUP

2 Service Providers

5 Dealmakers

£ 77 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy